NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 492 / 982

  1. Current advances in research in treatment and recovery: Nicotine addiction.2019 · PubMed
  2. Current perspectives on the opioid crisis in the US healthcare system2019 · OpenAlex
  3. Current prevalence pattern of tobacco smoking in Nigeria: a systematic review and meta-analysis2019 · OpenAlex
  4. Current Research: Analysis of ceramic vessel residues from the Washington Square Mound Site (41NA49) for evidence of peyote use by the Caddo in the 13th-15th centuries A.D.2019 · Crossref
  5. Current understanding of bipolar disorder: Toward integration of biological basis and treatment strategies2019 · OpenAlex
  6. Current Understanding of Methamphetamine-Associated Metabolic Changes Revealed by the Metabolomics Approach2019 · Crossref
  7. Cutaneous Crospovidone: A Newly Described Foreign Body Due to Illicit Drug Abuse2019 · Crossref
  8. Cutting-Edge Search for Safer Opioid Pain Relief: Retrospective Review of Salvinorin A and Its Analogs2019 · OpenAlex
  9. Cyberpunk in a Transnational Context2019 · OpenAlex
  10. Cyclic vomiting syndrome: Pathophysiology, comorbidities, and future research directions2019 · OpenAlex
  11. Cynthia Carson Bisbee, Paul Bisbee, Erika Dyck, Patrick Farrell, James Sexton and James W. Spisak (eds), Psychedelic Prophets: The Letters of Aldous Huxley and Humphry Osmond2019 · OpenAlex
  12. Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation2019 · Crossref
  13. Cytokine Research in Depression: Principles, Challenges, and Open Questions2019 · OpenAlex
  14. Cytotoxic Potentials of Betel Quid and its Components2019 · Crossref
  15. CZECHOSLOVAK REPUBLIC IN THE FOREIGN TRADE OF SOVIET UKRAINE IN 1920-19222019 · Crossref
  16. d-Lysergic acid diethylamide has major potential as a cognitive enhancer2019 · OpenAlex
  17. D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?2019 · OpenAlex
  18. Daily Motives for Alcohol and Marijuana Use as Predictors of Simultaneous Use Among Young Adults2019 · OpenAlex
  19. Daily, high‐potency cannabis linked to first psychosis2019 · Crossref
  20. Daily, high‐potency cannabis use linked to first‐episode psychosis2019 · Crossref
  21. Damage reduction and alcohol drinking reduction programs in social welfare homes as an alternative to traditional abstinence interventions2019 · Crossref
  22. Dancing with Deterrents: Understanding the Role of Abuse-Deterrent Opioid Formulations and Naloxone in Managing Cancer Pain2019 · OpenAlex
  23. Dangerous Chemical Agents: General and Odonto-Stomatological Aspects with Importance in Forensic Toxicology2019 · Crossref
  24. DARK Classics in Chemical Neuroscience: Arecoline2019 · OpenAlex
  25. DARK Classics in Chemical Neuroscience: Gamma-Hydroxybutyrate (GHB)2019 · OpenAlex
  26. Dark Classics in Chemical Neuroscience: Δ 9 -Tetrahydrocannabinol2019 · OpenAlex
  27. Data on opioid marketing could fuel efforts to restrict drug companies2019 · Crossref
  28. Data on the optimisation and validation of a liquid chromatography-high-resolution mass spectrometry (LC-HRMS) to establish the presence of phosphodiesterase 5 (PDE5) inhibitors in instant coffee premixes2019 · OpenAlex
  29. Dating violence (DV): a systematic meta-analysis review2019 · OpenAlex
  30. Datura innoxia Mill. (Solanaceae), a new alien species in the flora of Bosnia and Herzegovina2019 · Crossref
  31. Datura stramonium, a potential toxic plant2019 · OpenAlex
  32. De-commoditizing Ethiopian coffees after the establishment of the Ethiopian Commodity Exchange: an empirical investigation of smallholder coffee producers in Ethiopia2019 · Crossref
  33. De-mythologizing and re-branding of kava as the new ‘world drug’ of choice2019 · OpenAlex
  34. Dealing with fatherhood: Paternal identities among men in the illegal drug economy2019 · Crossref
  35. Death by Opioids: Are there non-addictive scientific solutions?2019 · OpenAlex
  36. Deceptive Dynamics in Drug Addiction and Their Role in Control Beliefs and Health Status Reporting: A Study on People With Substance Use Disorder in Treatment2019 · Crossref
  37. Decoding the Mechanism of Action of Rapid-Acting Antidepressant Treatment Strategies: Does Gender Matter?2019 · OpenAlex
  38. Decreased Cigarette Smoking but No Change in Use of Electronic Cigarettes Following a University-Wide Smoking Ban2019 · Crossref
  39. Decreased directed functional connectivity in the psychedelic state2019 · OpenAlex
  40. Decreased Expression of Cannabinoid Receptors in the Eutopic and Ectopic Endometrium of Patients with Adenomyosis2019 · OpenAlex
  41. Decreased Level of Blood MicroRNA-133b in Men with Opioid Use Disorder on Methadone Maintenance Therapy2019 · Crossref
  42. Decreasing risk among HIV patients on opioid therapy for chronic pain: Development of the TOWER intervention for HIV care providers2019 · OpenAlex
  43. Decriminalizing drug addiction: the effects of the label2019 · Crossref
  44. Deep Vein Thromboses in Injecting Drug Users: Meanings, Bodily Experiences, and Stigma2019 · Crossref
  45. Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis2019 · OpenAlex
  46. DEFINING ‘PERSONAL CONSUMPTION’ IN DRUG LEGISLATION AND SPANISH CANNABIS CLUBS2019 · Crossref
  47. Definition and Validity of the Construct “Problematic Khat Use”: A Systematic Review2019 · Crossref
  48. Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis2019 · OpenAlex
  49. Demographic, Cannabis Use, and Depressive Correlates of Cannabis Use Consequences in Regular Cannabis Users2019 · Crossref
  50. Depenalization, diversion and decriminalization: A realist review and programme theory of alternatives to criminalization for simple drug possession2019 · OpenAlex
  51. Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development2019 · OpenAlex
  52. Deploying Plural Drug Policies after the ‘War on Drugs’: A Geographical Perspective2019 · Crossref
  53. Deprescribing benzodiazepines among hospitalised older adults: quality improvement initiative2019 · Crossref
  54. Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines2019 · OpenAlex
  55. Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment.2019 · PubMed
  56. Deregulation of Biologically Significant Genes and Associated Molecular Pathways in the Oral Epithelium of Electronic Cigarette Users2019 · OpenAlex
  57. Derivative UV Spectrophotometric Detection of Some Common Pesticides in Simulated Samples of Beverages2019 · Crossref
  58. Derivative UV-Vis Spectrophotometric Analysis of Caramel in Some Common Liquor Samples2019 · Crossref
  59. Descriptive Norms but not Harm Reduction Strategies as a Mediator of Personalized Boosters After a Computerized College Drinking Intervention2019 · Crossref
  60. Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in Humans2019 · OpenAlex
  61. Descriptive, observational study of pharmaceutical and non-pharmaceutical arrests, use, and overdoses in Maine2019 · OpenAlex
  62. Design of integrated database of smart coffee enterprise support system for coffee small medium enterprise2019 · Crossref
  63. Design, Fabrication, and Performance Evaluation of a Batch-Type Fluidized Bed Coffee Roaster for Small-Scale Coffee Growers2019 · Crossref
  64. Designer Benzodiazepines: A Review of Published Data and Public Health Significance2019 · OpenAlex
  65. Designing an Individually Tailored Multilevel Intervention to Increase Engagement in HIV and Substance Use Treatment Among People Who Inject Drugs With HIV: HPTN 0742019 · OpenAlex
  66. Designing, implementing and evaluating the overdose response with take‐home naloxone model of care: An evaluation of client outcomes and perspectives2019 · OpenAlex
  67. Detectability of Dissociative Psychoactive Substances in Urine by Five Commercial Phencyclidine Immunoassays2019 · Crossref
  68. Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use?2019 · Crossref
  69. Detecting Effective Tobacco Control Messages via Linguistic Analysis and Item Response Theory2019 · Crossref
  70. Detection and Identification of Kratom (Mitragyna speciosa) and Marijuana (Cannabis sativa) by a Real‐Time Polymerase Chain Reaction High‐Resolution Melt Duplex Assay,2019 · Crossref
  71. Detection of cocaine and its metabolites in whole blood and plasma following a single dose, controlled administration of intranasal cocaine2019 · Crossref
  72. Detection of Drugs and Their Metabolites in Oral Fluid2019 · OpenAlex
  73. Detection of legal highs in the urine of methadone‐treated patient by LC‐MS2019 · OpenAlex
  74. Deterioro social y participación en el tráfico de drogas en el estado de Sonora2019 · Crossref
  75. Determinants of tobacco cultivation in Bangladesh2019 · Crossref
  76. Determination of adulterants in whey protein food supplements by liquid chromatography coupled to Orbitrap high resolution mass spectrometry2019 · Crossref
  77. Determination of Antidepressants and Antipsychotics in Dried Blood Spots (DBSs) Collected from Post-Mortem Samples and Evaluation of the Stability over a Three-Month Period2019 · OpenAlex
  78. Determination of Cocaine by Square Wave Voltammetry with Carbon Paste Electrodes2019 · OpenAlex
  79. Determination of Common Pharmaceutical Adulterants in Herbal Medicinal Products Used in the Treatment of Opioid Addiction2019 · Crossref
  80. Determination of lumpy skin disease virus in bovine meat and offal products following experimental infection2019 · OpenAlex
  81. Determination of New Psychoactive Substances in Whole Blood Using Microwave Fast Derivatization and Gas Chromatography/Mass Spectrometry2019 · OpenAlex
  82. Determination of preservative chemicals leaching from treated bamboo sticks in betel farm soil and betel leaf2019 · Crossref
  83. Determination of Psychoactive Mitragynine Drug in Suspected Kratom Species Collected from Various Geographical Areas in the Philippines: A Pilot Study on Existing Local Plant-based New Psychoactive Substance (NPS)2019 · OpenAlex
  84. Determination of Selected Opiates in Hair Samples Using Microextraction by Packed Sorbent: A New Approach for Sample Clean-up2019 · Crossref
  85. Determination of synthetic cathinone α‐pyrrolidinovalero‐phenone and its metabolite in urine using solid‐phase extraction and gas chromatography–mass spectrometry2019 · OpenAlex
  86. DETERMINAÇÃO DE DESIGNER DRUGS EM SALIVA POR PAPER SPRAY MASS SPECTROMETRY2019 · OpenAlex
  87. Determining the Socio-Economic Importance of Saffron as an Alternative Product to Opium Production in Afghanistan2019 · Crossref
  88. Developing E. coli-E. coli co-cultures to overcome barriers of heterologous tryptamine biosynthesis2019 · OpenAlex
  89. Developing Insect Pest Management Systems for Hemp in the United States: A Work in Progress2019 · OpenAlex
  90. Developing neuroscience-based treatments for alcohol addiction: A matter of choice?2019 · OpenAlex
  91. Developing Robust Standardised Analytical Procedures for Cannabinoid Quantification: Laying the Foundations for an Emerging Cannabis-Based Pharmaceutical Industry2019 · Crossref
  92. Developing the Spirituality in Recovery Framework: The Function of Spirituality in 12-Step Substance Use Disorder Recovery2019 · Crossref
  93. Development and application of a forensic toxicological library for identification of 56 natural toxic substances by liquid chromatography–quadrupole time-of-flight mass spectrometry2019 · Crossref
  94. DEVELOPMENT AND APPLICATION OF A RAPID SCREENING METHOD FOR DETERMINATION OF NEW PSYCHOACTIVE SUBSTANCES AND THEIR METABOLITES IN URINE2019 · Crossref
  95. Development and Guiding Principles of the Icelandic Model for Preventing Adolescent Substance Use2019 · OpenAlex
  96. Development and validation of a GC–MS/MS method for the determination of 11 amphetamines and 34 synthetic cathinones in whole blood2019 · OpenAlex
  97. Development and validation of a liquid chromatography‐tandem mass spectrometry method for simultaneous detection of 10 illicit drugs in oral fluid collected with FLOQSwabs™ and application to real samples2019 · Crossref
  98. Development and Validation of the Volitional Components Inventory for Drug Rehabilitation2019 · Crossref
  99. Development of a Cascade of Care for responding to the opioid epidemic.2019 · PubMed
  100. Development of technology for the hemp stalks preparation2019 · OpenAlex